3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Multiple Myeloma
13
Prostatic Neoplasms
10
Osteoporosis
8
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
5
Fractures, Bone
4
Neoplasms, Plasma Cell
3
Lymphoma
3
Bone Diseases, Metabolic
3
Bone Diseases
3
Spinal Cord Compression
2
Pain
2
Ovarian Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Renal Cell
2
Bone Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Pleural Effusion, Malignant
1
Paraproteinemias
1
Oligodendroglioma
1
Neoplastic Processes
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Interventions
Doxorubicin
6
pazopanib
5
Gemcitabine
4
pembrolizumab
3
Trabectedin
3
Sorafenib
3
Docetaxel
3
Dacarbazine
3
eribulin
2
Sunitinib
2
Radiotherapy, Conformal
2
Radiotherapy
2
Nivolumab
2
Letrozole
2
Ifosfamide
2
Bevacizumab
2
tremelimumab
1
temsirolimus
1
saracatinib
1
sapanisertib
1
rucaparib
1
romidepsin
1
olaratumab
1
mocetinostat
1
liposomal doxorubicin
1
lenvatinib
1
indolepropanol phosphate
1
durvalumab
1
cixutumumab
1
cabozantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leiomyosarcoma
×
Zoledronic Acid
×
Clear all
No trials found.